1 Foghorn Therapeutics Inc Receivables Turnover Ratio (FHTX), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Foghorn Therapeutics Inc   (NASDAQ: FHTX)
 

Foghorn Therapeutics Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Foghorn Therapeutics Inc Balance Sheet, in the first quarter 2026, company has not reported any Accounts receivable.
See Foghorn Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector 427 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 2712 to 2808.

What is Receivable Turnover Ratio?
What is Foghorn Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FHTX Receivables Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change -45.11 % 223.77 % 4.42 % 9.71 % 17.86 %
Receivable Turnover Ratio (TTM) - - - - -
FHTX's Total Ranking # 2808 # 2712 # 2986 # 1955 # 2041
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change -64.67 % 13.42 % 7.89 % 26.97 % 108.4 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 144
Healthcare Sector # 428
Overall Market # 2808

Receivable Turnover Ratio Statistics
High Average Low
0.14 0.07 0
(Dec 31 2025)   (Sep 30 2021)





FHTX Company Profile • Back to FHTX Efficiency Comparisons • Compare FHTX Receivables Turnover Ratio to its Competitors

Financial Statements
Foghorn Therapeutics Inc 's Accounts Receivable $ 0 Millions Visit FHTX's Balance sheet
Foghorn Therapeutics Inc 's Sales TTM $ 28 Millions Visit FHTX's Income Statement
Sources of FHTX's Revenues Visit FHTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FHTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FHTX's Growth Rates FHTX's Roa FHTX's Inventory Turnover Ratio FHTX's Dividend Comparisons
FHTX's Profitability Ratios FHTX's Roi FHTX's Asset Turnover Ratio FHTX's Dividend Growth
FHTX's Valuation Ratios FHTX's Roe FHTX's Financial Strength Ratios FHTX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026

Date modified: 2026-08-29T17:42:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.